Conceptus buys Ovion birth control patents
This article was originally published in The Gray Sheet
Maker of the Essure non-incisional permanent birth control device buys Ovion female sterilization technology patents from American Medical Systems for $23.6 million on Oct. 5. The deal releases Conceptus from its royalty obligations under a 2003 agreement and increases the firm's ability to develop a next-generation version of Essure, according to the company. AMS had acquired the Ovion technology in 2005
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.